Source: MSD
Date published: 20/11/2009 16:23
MSD has received approval from the EC for sitagliptin (Januvia®) as add-on to insulin (with or without metformin) when diet and exercise plus stable dosage of insulin do not provide adequate glycaemic control for the treatment of type 2 diabetes.
Comment text: